AAP Implantate: Balanced EBITDA in H1, Trauma segment turns positive

Posted on August 14, 2024 by Vaseline

In the first half of 2024, our revenue increased by 10% to EUR 6.4 million, driven by strong performance in EMEA. EBITDA reached break-even, which represents a significant improvement, and operating cash flow …

Posted in bookmarks

Previous: These features are available in the new version › Macerkopf

Next: Last Station of the European Tour: Taylor Swift Throws Huge Party for His Joint Team

bookmarks

The best restaurants, bars and bookers

Vaseline
October 23, 2024
0

Josh Hickey worked at Bücher and Bars Hydra has great literary significance. A positive approach to reading could begin with the works of the best-known […]

bookmarks

EDAP reports second quarter 2024 financial results

Vaseline
August 28, 2024
0

Record Q2 2024 total global revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% versus Q2 2023 Record first half 2024 total global revenue […]

bookmarks

Cytokinetics presents new data on the safety and long-term use of Aficamten at the European Society of Cardiology Congress 2024

Vaseline
September 1, 2024
0

Data from integrated safety analysis of three clinical studiesAficamten’s Enhanced Robust Safety Profile Analysis of FOREST-HCM shows successfulWithdrawal of standard care medicinesin patients with obstructive […]

Related Posts

The best restaurants, bars and bookers

EDAP reports second quarter 2024 financial results

Cytokinetics presents new data on the safety and long-term use of Aficamten at the European Society of Cardiology Congress 2024